Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro can cause muscle aches and general body discomfort in some people, particularly in the days after a new dose or a dose increase. It is not one of the medicine's most common side effects, but it is real, it is documented, and it usually passes. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is suitable for you before anything is dispensed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When people search this question they often have a specific worry in mind, that tirzepatide is somehow damaging muscle tissue, or causing a condition like the myopathy associated with some other medicines. That concern is understandable, but it is not what the evidence suggests is happening here. Mounjaro works on two gut-hormone receptors, GIP and GLP-1, to reduce appetite and slow the rate food leaves your stomach. Muscle toxicity is not a mechanism that comes with that action.
What is reported in the tirzepatide clinical programme and the published prescribing information is a more general picture: some people feel achy, fatigued, or flu-like, especially in the first week or two after a dose change. The body is adapting. Nausea and gastrointestinal effects get most of the attention in clinical write-ups, but musculoskeletal pain does appear as a side effect in the NHS tirzepatide medicines page, listed among the less common effects. That is worth knowing, because it means your prescriber has the information to help.
One thing our prescribers hear regularly is: "I thought I was coming down with something." Often, what people describe as a flu-like ache (sore limbs, heaviness, tiredness) arrives around the time of a new injection and settles within a few days. If you want a fuller picture of what it means when Mounjaro makes your body ache, including why it happens and what to expect, that page goes into more detail. That pattern matters, because it points toward the medicine rather than an unrelated illness.
Timing is the clearest guide. If you notice generalised body aches in the one to four days after your weekly injection, particularly during your first few pens or after moving to a higher strength, a treatment-related cause is plausible. The effect tends to be mild and self-limiting. Keeping well hydrated helps, because dehydration compounds fatigue and can make muscular discomfort feel sharper than it is.
Back pain specifically is something people ask about separately, if that is your main concern, there is more detail on our page covering Mounjaro and back ache. Temperature sensitivity (feeling unusually cold or unusually warm) can also accompany the adjustment phase; the pages on feeling cold on Mounjaro and feeling hot on Mounjaro cover those separately.
The signals that need prompt medical attention are different in character. Pain that is severe, located in the centre or upper part of the abdomen, and that spreads toward your back (especially alongside vomiting) should not be managed at home. The MHRA's January 2026 Drug Safety Update for GLP-1 medicines highlighted acute pancreatitis as a known, infrequent but serious side effect, and severe abdominal pain is its cardinal symptom. Urgent medical assessment is the right response to that picture, not waiting to see whether it settles.
Joint pain, limb pain, and injection-site soreness are also documented; they are generally minor and improve as the body adjusts to treatment.
Most of what helps is straightforward. Drink enough water, gastrointestinal side effects on tirzepatide can quietly reduce fluid intake, and even mild dehydration makes aches feel worse. Some people also notice that stomach rumbling on Mounjaro accompanies these gastrointestinal changes, which is a related sign that the digestive system is adjusting. Protein intake matters too: some people on GLP-1 treatment eat so little that muscle maintenance suffers, which can register as general soreness over time. A prescriber or dietitian can advise on practical ways to protect that.
Injection-site rotation (abdomen, thigh, or upper arm, each week a different spot) reduces localised soreness at the injection point itself. The NHS medicine information for tirzepatide covers safe technique, and your Patient Information Leaflet has the detail on storage and handling. Never amend your dose schedule to manage side effects without talking to your prescriber first; that is what they are there for.
If you are wondering how these effects compare to what you might notice on semaglutide, or what the broader side-effect picture looks like across weight-loss treatments, our weight-loss treatments overview puts it in context. And if your main question is cost rather than side effects, the background on Mounjaro pricing in the UK explains what has changed and why.
General body discomfort on Mounjaro is real, usually brief, and manageable. If yours is not brief, or not manageable, that is exactly the kind of thing a prescriber needs to hear about. Speak to our prescribers directly, our contact page has the details, and you can also raise any concerns through the FAQs or via the aftercare team seven days a week.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.